Skip to main content
SpringerLink
Log in

Tigecycline associated with increased mortality risk

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Drug Safety Communication: increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections. Internet Document: [2 pages], 1 Sep 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tigecycline associated with increased mortality risk. React. Wkly. 1318, 6 (2010). https://doi.org/10.2165/00128415-201013180-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013180-00013

Keywords

Search

Navigation